Top 22 Semma Therapeutics investors
The most complete profiles first. Showing 22 of 22.
Carol SuhVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
David CruikshankVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHardwarePortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Katie ElliasVerified
Venture Capital, Investor · United States
SeedAngularJSEducationBiotechnologyElectronic Health Records (EHR)Portfolio: Tetragenetics, Biolinq, Enthera, Provention Bio and 19 more
Verified email available
Sean KendallVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareEnterprise SoftwareEnergyChemicalPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Brian GoodmanVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Luke EvninVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Mark McDonnellVerified
Venture Capital · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Shinichiro FuseVerified
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Todd FoleyVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Verified email available
Tom BrennanVerified
Venture Capital, Private Equity Firm · United States
Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Corey Ritter
Venture Capital, Investor · United States
Series BHealth CareLife ScienceRoboticsManufacturingPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Ed Hurwitz
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more
Contact details available
Nilay Thakar
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Stephen Curtis
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Steve Gillis
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more
Contact details available
Steven St. Peter, M.D.
Venture Capital, Investor · United States
SeedBiotechnologyPharmaceuticalsPortfolio: Tetragenetics, EKR Therapeutics, Biolinq, Enthera and 20 more
Contact details available
Christiana Bardon M.D.
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareGeneticsInvestment ManagementLife SciencePortfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Leigh Zawel
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Robert Nelsen
Venture Capital, Investor · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more
Contact details available
Vinay Bhaskar
Venture Capital, Private Equity Firm · United States
Health CareGeneticsLife ScienceInformation Technology (IT)Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more
Contact details available
Yury Kukushkin
Venture Capital · United States
Portfolio: Tetragenetics, Biolinq, Enthera, Provention Bio and 19 more
Contact details available
Verified email available
By investment stage
By location
Related industries
Most-backed portfolio companies
- ImmusanT12
- Sonoma BioTherapeutics12
- EGenesis12
- Theraclone Sciences10
- Walden Biosciences9
- Tetherex Pharmaceuticals9
- Proteon Therapeutics9
- Celladon9
- Vividion Therapeutics9
- Boundless Bio9
- BlackThorn Therapeutics9
Frequently asked questions
How many Semma Therapeutics investors are on Angel Roster?
Angel Roster lists 22 Semma Therapeutics investors. 11 of them (50%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (21), Private Equity Firms (13) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Semma Therapeutics investors invest in?
Among those that list a stage, the most common are Series B (6) and Seed (4).
Where are Semma Therapeutics investors based?
Most are based in the United States (21) and the United Kingdom (1).
Which companies have Semma Therapeutics investors backed?
The most-backed portfolio companies among them are ImmusanT (12), Sonoma BioTherapeutics (12), EGenesis (12), Theraclone Sciences (10) and Walden Biosciences (9).
How do I contact Semma Therapeutics investors?
Create a free Angel Roster account to search and filter all 22, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.